Letter | Published:

Fusion of Sendai virus with the target cell membrane is required for T cell cytotoxicity

Nature volume 274, pages 689691 (17 August 1978) | Download Citation

Subjects

Abstract

INFECTION of mice with viruses can generate cytotoxic T lymphocytes (CTL) which show restricted specificity for target cell lysis. Specific lysis requires that the virus used to prime the target cells must be of the same type as that used to sensitise the CTL, and that both target and CTL cells must express the same major histocompatability complex (MHC) gene product(s). The nature of the viral gene product(s) and their interaction with the MHC gene product(s) have been the subject of recent stud1–5. Previously we used Sendai virus to show that lysable target cells can be obtained using membrane vesicles which contain only the viral glycoproteins, indicating that these may be the specific viral gene products involved in target formation5. Sendai virus contains two glycoproteins—the haemagglutinin-neuraminidase (HANA) which promotes attachment of virus to cells and the fusion protein (F) which is involved in subsequent virus cell fusion7–9. Both activities are necessary for insertion of these viral glycoproteins into the plasma membrane of the cell10. In this letter we suggest that the insertion of the viral glycoproteins into the cell membrane is an essential step in target cell formation since we can show that virus containing an inactive fusion protein precursor (F0) cannot elicit T cell cytotoxicity unless the fusion activity is generated by proteolytic cleavage of the precursor. Sugamura et al.6 have suggested that it is primarily the F glycoprotein of the Sendai virus envelope which is essential for the formation of the target antigen, as virus lacking the functional activities of F following trypsin digestion was inactive in priming target cells for T cell killing. However, we show that proteolytic inactivation of either of the two glycoproteins (F or HANA) of virus used to prime target cells will abolish the cytotoxic response.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    & Nature 248, 701–702 (1974).

  2. 2.

    & Nature 264, 145–152 (1976).

  3. 3.

    & J. exp Med. 145, 523–539 (1977).

  4. 4.

    & Eur. J. Immun. 5, 245–251 (1975).

  5. 5.

    , & Nature 267, 160–163 (1977).

  6. 6.

    , , & Nature 270, 251–253 (1977).

  7. 7.

    , & Virology 55, 242–253 (1973).

  8. 8.

    & J. Virol. 12, 1457–1465 (1973).

  9. 9.

    & Virology 57, 475–490 (1974).

  10. 10.

    , and in Virus Infection and the Cell Surface (eds Poste, G. & Nicolson, G. E.) 129–155 (North-Holland, Amsterdam, 1977).

Download references

Author information

Affiliations

  1. Protein Chemistry Laboratory, Imperial Cancer Research Fund

    • MARY-JANE GETHING
  2. Tumour Immunology Unit, University College, London WC1, UK

    • ULRICH KOSZINOWSKI
  3. Present address: Institut für Immunologie und Genetics, Deutches Krebs Forschungscentrum, Heidelberg, FRG.

    • ULRICH KOSZINOWSKI
  4. Protein Chemistry Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2, UK

    • MICHAEL WATERFIELD

Authors

  1. Search for MARY-JANE GETHING in:

  2. Search for ULRICH KOSZINOWSKI in:

  3. Search for MICHAEL WATERFIELD in:

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/274689a0

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.